Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Law Econ ; 53(3): 319-351, 2022.
Article in English | MEDLINE | ID: mdl-35923352

ABSTRACT

Public authorities in many jurisdictions are concerned about the proliferation of illegal content and products on online platforms. One often discussed solution is to make the platform liable for third parties' misconduct. In this paper, we first identify platform incentives to stop online misconduct in the absence of liability. Then, we provide an economic appraisal of platform liability that highlights the intended and unintended effects of a more stringent liability rule on several key variables such as prices, terms and conditions, business models, and investments. Specifically, we discuss the impact of the liability regime applying to online platforms on competition between them and the incentives of third parties relying on them. Finally, we analyze the potential costs and benefits of measures that have received much attention in recent policy discussions.

2.
J Health Econ ; 74: 102371, 2020 12.
Article in English | MEDLINE | ID: mdl-32920244

ABSTRACT

Governments worldwide are increasingly concerned about the booming use of CBD (cannabidiol) products. However, we know little about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using unique and high-frequency data on prescription drug sales and by exploiting the staggered local availability of the new product in each Italian province, we document a significant substitution effect between light cannabis and anxiolytics, sedatives, opioids, anti-depressants and anti-psychotics. Results are informative for regulators and suggest that bans on light cannabis use would disregard the needs of patients to seek effective reliefs of their symptoms.


Subject(s)
Cannabidiol , Cannabis , Prescription Drugs , Analgesics, Opioid , Humans , Italy
3.
Health Econ ; 28(11): 1377-1382, 2019 11.
Article in English | MEDLINE | ID: mdl-31429153

ABSTRACT

The spread of fake news and misinformation on social media is blamed as a primary cause of vaccine hesitancy, which is one of the major threats to global health, according to the World Health Organization. This paper studies the effect of the diffusion of misinformation on immunization rates in Italy by exploiting a quasi-experiment that occurred in 2012, when the Court of Rimini officially recognized a causal link between the measles-mumps-rubella vaccine and autism and awarded injury compensation. To this end, we exploit the virality of misinformation following the 2012 Italian court's ruling, along with the intensity of exposure to nontraditional media driven by regional infrastructural differences in Internet broadband coverage. Using a Difference-in-Differences regression on regional panel data, we show that the spread of this news resulted in a decrease in child immunization rates for all types of vaccines.


Subject(s)
Communication , Patient Acceptance of Health Care/statistics & numerical data , Vaccines/therapeutic use , Child , Diphtheria-Tetanus-Pertussis Vaccine/therapeutic use , Humans , Italy , Measles-Mumps-Rubella Vaccine/therapeutic use , Patient Acceptance of Health Care/psychology , Poliovirus Vaccines/therapeutic use , Social Media , Vaccination Coverage/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...